Article info

other Versions

PDF
Extended report
Treating to target matrix metalloproteinase 3 normalisation together with disease activity score below 2.6 yields better effects than each alone in rheumatoid arthritis patients: T-4 Study
  1. Correspondence to Yukitomo Urata, Department of Rheumatology, Seihoku Chuo Hospital, 41 Nunoyacho, Gosyogawara 037-0053, Japan; yurata{at}dream.com
View Full Text

Citation

Urata Y, Uesato R, Tanaka D, et al
Treating to target matrix metalloproteinase 3 normalisation together with disease activity score below 2.6 yields better effects than each alone in rheumatoid arthritis patients: T-4 Study

Publication history

  • Received July 25, 2011
  • Accepted July 25, 2011
  • First published October 21, 2011.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.